Month: March 2017

Atlantic News

Atlantic Therapeutics receives €15 million in funding round

Atlantic Therapeutics Group Ltd, the Galway-headquartered medical device developer of non-invasive pelvic floor strengthening and nerve stimulation products, has successfully completed a €15 million growth capital financing, enabling it to move forward with its next phase of growth and treat millions of people across the globe who suffer from bladder weakness, clinically known as stress …

Atlantic Therapeutics receives €15 million in funding round Read More »

Medlumics News

MedLumics Secures €34m in Series B Funding

MedLumics, a cardiac device company specializing in optically guided minimally invasive instruments, announced today that it has raised 34.4 million Euros in financing that will be used to help advance the product and clinical development of the company’s AblaView catheter, intended for the treatment of atrial fibrillation (AF) and other arrhythmias. This financing is the …

MedLumics Secures €34m in Series B Funding Read More »

Pq Bypass News 2

PQ Bypass Announces CE Mark for DETOUR Percutaneous Bypass

Seroba’s investee company, PQ Bypass, today announced CE (Conformité Européenne) Mark approval for a trio of proprietary devices: TORUS™ Stent Graft System, PQ Snare, and PQ Crossing Device, which enables physicians to perform a fully percutaneous femoral-popliteal bypass in patients with TransAtlantic InterSociety (TASC) II C and D lesions in the superficial femoral artery due …

PQ Bypass Announces CE Mark for DETOUR Percutaneous Bypass Read More »

T: 353 (0)1 633 4028

18 Herbert Street
Dublin 2
D02 FK19
Ireland

Scroll to Top